As the healthcare industry shifts towards a more value-based system, payers, physicians, patients and pharmaceutical companies are paying more attention to the costs and benefits of new treatments. Steven D. Pearson, MD, has been interested in those topics for a long time and has emerged as a leading voice when it comes to comparative effectiveness research and health policy.